The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
China's Boji joins hands with AstraZeneca to promote TCM R&D
Boji Medical Technology Co., Ltd (Boji, 300404.SZ) signed a memorandum of strategic cooperation with the Chengdu office of multinational pharmaceutical giant AstraZeneca on November 5, during the fifth China International Import Expo, reported China Securities News.
November07,2022
AstraZeneca to debut four new drugs at upcoming China International Import Expo in Shanghai
AstraZeneca, a leading global pharmaceutical company, announced to unveil four new drugs for the first time at the upcoming fifth China International Import Expo (CIIE), which will be held in Shanghai from Nov. 5 to 10.
November02,2022
AstraZeneca will continue to increase investment in China, company official
AstraZeneca, the British pharmaceutical giant, is optimistic about China's economic prospects and health industry development, and will continue to increase its investmentin China, said Leon Wang, executive vice president of AstraZeneca, Chinanews.com reported on Wednesday.
June30,2022
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
